Bell Potter initiated cover yesterday. Here's a wee snip
"Investment View – Initiate with a Buy, PT $1.92 We initiate coverage on ELX with a Buy and PT of $1.92. The PT is generated using a blend of three valuation methodologies: DCF, EV/EBITDA and EV/Sales. ELX has aggressive growth potential and we forecast strong double digit growth in revenue and earnings over the next 5 years. We also believe ELX is undervalued when compared to the high growth small cap medtech companies in the US trading at an average 6.8x 2018 EV/sales vs. ELX trading at 1.5x. In our view, iTrack business alone can support our PT for ELX given the US$500m-US$700m recent acquisitions in the MIGS space. "
losses expected in their forward calc's for both this year and next year, so need to see through that I guess.
Ann: Ellex Company Update, page-6
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.015(10.3%) |
Mkt cap ! $36.64M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 16.0¢ | 14.5¢ | $38.73K | 257.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 84655 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 271846 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |